Pliant Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Pliant Therapeutics Inc
TickerPLRX
CIK #0001746473
CUSIP729139105
SectorLife Sciences - Pharmaceutical Preparations
Address260 Littlefield Avenue, South San Francisco, CA 94080
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Pliant Therapeutics Inc 2020-01-09 100.4 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001746473] 10-K
[0001746473] 10-Q
[0001746473] 3
[0001746473] 4
[0001746473] 8-K
[0001746473] D
[0001746473] SC 13D
[0001746473] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Citadel Advisors LLC Pliant Therapeutics Inc [2026-02-09] 0.0
Citadel Advisors LLC Pliant Therapeutics Inc [2026-01-30] 0.0
Citadel Advisors LLC Pliant Therapeutics Inc [2026-01-22] 0.0
Woodline Partners LP Pliant Therapeutics Inc [2025-11-14] 0.0
Morgan Stanley Pliant Therapeutics Inc [2025-08-06] 0.0
Tang Capital Management LLC Pliant Therapeutics Inc [2025-03-10] 0.0
Redmile Group LLC Pliant Therapeutics Inc [2024-11-14] 5.3
Paradigm Biocapital Advisors LP Pliant Therapeutics Inc [2024-10-04] 5.03
First Light Asset Management LLC Pliant Therapeutics Inc [2024-02-14] 6.07
Blue Owl Capital Holdings LP Pliant Therapeutics Inc [2024-02-14] 5.02
Price T Rowe Associates Inc /MD/ Pliant Therapeutics Inc [2024-02-14] 6.3
Vanguard Group Inc Pliant Therapeutics Inc [2024-02-13] 5.12
Laurion Capital Management LP Pliant Therapeutics Inc [2024-02-08] 5.98
BlackRock Inc Pliant Therapeutics Inc [2024-01-25] 8.0
Deep Track Capital LP Pliant Therapeutics Inc [2023-03-20] 5.27
CHI Advisors LLC Pliant Therapeutics Inc [2021-03-02] 6.6
Third Rock Ventures III LP Pliant Therapeutics Inc [2021-02-16] 16.5
Eventide Asset Management LLC Pliant Therapeutics Inc [2021-02-12] 8.0
FMR LLC Pliant Therapeutics Inc [2020-07-10] 0.0
Novartis Institutes for Biomedical Research Inc Pliant Therapeutics Inc [2020-06-15] 6.1
Redmile Group LLC Pliant Therapeutics Inc [2020-06-09] 0.6
Form 3/4/5 Filer 2011 - 2026
Cline Darren S
Pliant Therapeutics Inc
Crowell Gayle A
MCCOURT Thomas A
Krognes Steve E
Curnutte John T
Huh Hoyoung
Coulie Bernard
Kuo Minnie
Cummings Keith Lamont
Cheung Lily
Pyott David E I
Bruhn Suzanne Louise
Knobil Katharine
Ouimette Mike
Hull Hans
Lefebvre Eric
Shah Smital
Third Rock Ventures III LP
Third Rock Ventures GP III LP
TRV GP III LLC
Tepper Robert I
Exter Neil
Homcy Charles J
Howes Barbara
Third Rock Ventures GP IV LP
Third Rock Ventures IV LP
Starr Kevin P
Levin Mark J
TRV GP IV LLC
Redmile Group LLC
Green Jeremy
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Cheung Lily
Stock Option (Right to Buy) · derivative
2026-01-22 Grant 300,000 $0.00
Coulie Bernard
Stock Option (Right to Buy) · derivative
2026-01-22 Grant 1,230,000 $0.00
Kuo Minnie
Stock Option (Right to Buy) · derivative
2026-01-22 Grant 300,000 $0.00
Cummings Keith Lamont
Stock Option (Right to Buy) · derivative
2026-01-22 Grant 400,000 $0.00
Kuo Minnie
Common Stock
2026-01-20 Sell 6,917 $1.28 8,854
Cummings Keith Lamont
Common Stock
2026-01-20 Sell 24,002 $1.28 30,723
Coulie Bernard
Common Stock
2026-01-20 Sell 89,375 $1.28 114,400
Cheung Lily
Common Stock
2026-01-20 Sell 7,534 $1.28 9,644
MCCOURT Thomas A
Common Stock (Right to Buy) · derivative
2025-06-05 Grant 30,000 $0.00
Knobil Katharine
Common Stock (Right to Buy) · derivative
2025-06-05 Grant 30,000 $0.00
Bruhn Suzanne Louise
Common Stock (Right to Buy) · derivative
2025-06-05 Grant 30,000 $0.00
Crowell Gayle A
Common Stock (Right to Buy) · derivative
2025-06-05 Grant 30,000 $0.00
Krognes Steve E
Common Stock (Right to Buy) · derivative
2025-06-05 Grant 30,000 $0.00
Cline Darren S
Common Stock (Right to Buy) · derivative
2025-06-05 Grant 30,000 $0.00
Curnutte John T
Common Stock (Right to Buy) · derivative
2025-06-05 Grant 30,000 $0.00
Pyott David E I
Common Stock (Right to Buy) · derivative
2025-06-05 Grant 30,000 $0.00
Huh Hoyoung
Common Stock (Right to Buy) · derivative
2025-06-05 Grant 30,000 $0.00
Cheung Lily
Stock Option (Right to Buy) · derivative
2025-01-23 Grant 51,750 $0.00
Ouimette Mike
Stock Option (Right to Buy) · derivative
2025-01-23 Grant 70,000 $0.00
Hull Hans
Stock Option (Right to Buy) · derivative
2025-01-23 Grant 80,300 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 91 46,923,998
2025-12-31 97 44,142,740
2025-09-30 100 49,832,829
2025-06-30 114 51,181,649
2025-03-31 143 57,531,161
2024-12-31 163 60,343,144
2024-09-30 154 58,797,309
2024-06-30 146 59,670,949
2024-03-31 138 62,268,464
2023-12-31 136 59,572,558
2023-09-30 139 56,758,507
2023-06-30 147 55,583,354
Form 13F Holdings
Firm Period DFND Voting Shares
Marquette Asset Management LLC [2026-06-30] SOLE 0 174,500
Bond & Devick Financial Network Inc [2026-06-30] SOLE 100,160 100,160
Capital Advisors Ltd LLC [2026-06-30] SOLE 0 31
Farther Finance Advisors LLC [2026-06-30] SOLE 0 5
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com